About
Exicure
XCUR.US
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd.
Profile
- Company Name
- Exicure, Inc.
- Market
- NasdaqCM
- Founded
- Industry
- --
- Fiscal Year End
- December 31
- Website
- www.exicuretx.com